Home 
Bratislava Medical Journal 2017 Bratislava Medical Journal Vol.118, No.1, p.9-12, 2017
Bratislava Medical Journal 2017 Bratislava Medical Journal Vol.118, No.1, p.9-12, 2017
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.118, No.1, p.9-12, 2017 |
||
| Title: Galantamine has impact on immunity in mice exposed to keyhole limpet hemocyanin | ||
| Author: M. Pohanka, J. Zakova, J. Fusek | ||
| Abstract: OBJECTIVES: In this work, we hypothesized whether galantamine could interact with the cholinergic anti-inflammatory pathway and modulate immunity this way. BACKGROUND: Galantamine is a drug used for the therapy of Alzheimer disease. The drug inhibits enzyme acetylcholinesterase in the central nervous system, which causes better availability of neurotransmitter acetylcholine. METHODS: In the experiment, we immunized BALB/c laboratory mice by keyhole limpet hemocyanin (KLH) in combination with galantamine in a dose 0.02–0.5 mg/kg. The animals were sacrificed from 1 to 7 days after the substances applications and plasma was collected in order to examine immunochemical markers by enzyme-linked immunosorbent assay. RESULTS: We found significant drop in production of immunoglobulins and interleukin (IL) 4 level while IL2, IL4 and tumour necrosis factor α remained unaltered for the whole experiment. We infer that galantamine causes better availability of acetylcholine also in blood system, where the neurotransmitter interacts with nicotinic acetylcholine receptors on macrophages and initiates cholinergic anti-inflammatory pathway. CONCLUSIONS: In a conclusion, galantamine can cause lower efficacy of vaccination or immunity response to an infectious disease and the phenomenon should be taken into consideration in the current therapy (Tab. 1, Fig. 2, Ref. 24). |
||
| Keywords: acetylcholinesterase, alzheimer disease, cholinergic anti-inflammatory pathway, galantamine, inflammation, macrophage, inhibition. | ||
| Published online: 26-Jan-2017 | ||
| Year: 2017, Volume: 118, Issue: 1 | Page From: 9, Page To: 12 | |
| doi:10.4149/BLL_2017_002 |
||
|
|
 download file |
|